Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Swissoxa, Aksiprol, Lupoxa
Synonyms :
N-Acetyl-L-hydroxyproline
Class :
NSAIDs
Dosage Forms & StrengthsÂ
TabletÂ
200mgÂ
400mgÂ
600mgÂ
Cream Â
10%Â
Indicated for superficial burns
Apply cream on the affected area once daily
No data is available Â
Refer to the adult dosing and reduce the dose as per the ageÂ
oxaceprol decreases the effect of anti-hypertensives
oxaceprol decreases the effect of anti-hypertensives
oxaceprol decreases the effect of anti-hypertensives
oxaceprol decreases the effect of anti-hypertensives
oxaceprol decreases the effect of anti-hypertensives
oxaceprol decreases the effect of vitamin K antagonists
oxaceprol decreases the effect of vitamin K antagonists
oxaceprol decreases the effect of vitamin K antagonists
oxaceprol decreases the effect of vitamin K antagonists
oxaceprol decreases the effect of vitamin K antagonists
oxaceprol decreases the toxicity of lithium
Actions and SpectrumÂ
Frequency not definedÂ
Gastric PainÂ
DiarrheaÂ
NauseaÂ
HeadacheÂ
Skin rashesÂ
DizzinessÂ
Black Box Warning:Â
NoneÂ
Contraindication/Caution:Â
Contraindications:Â
Cautions:Â
Pregnancy consideration:Â Â
The drug is contraindicated during pregnancy. Â
Breastfeeding warnings:Â Â
It is unknown whether the drug is excreted in breast milk.Â
Pregnancy category:Â
Category A: Well-controlled and satisfactory studies show no risk to the fetus in the initial or later trimester.Â
<b>Category B: There was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: There was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.   Â
Category N: No data is available for the drug under this category.Â
Pharmacology:Â Â
oxaceprol is thought to have anti-inflammatory properties. It may inhibit the production of inflammatory mediators like prostaglandins and leukotrienes, which play a role in the inflammatory response. Â
oxaceprol may stimulate the synthesis of proteoglycans and collagen, essential components of healthy cartilage. This action can contribute to the protection and repair of joint cartilage.Â
Pharmacodynamics:Â
The drug has antioxidant properties, which means it protect the cells and tissues from damage caused by free radicals. Oxidative stress is thought in the progression of various diseases, including osteoarthritis.Â
Pharmacokinetics:Â
AbsorptionÂ
After oral administration, oxaceprol is absorbed from the gastrointestinal tract into the bloodstream.Â
DistributionÂ
It gets distributed in the body through the bloodstream, including to the joints and tissues affected by osteoarthritis.Â
MetabolismÂ
oxaceprol is primarily metabolized in the liver. The specific metabolic pathways and metabolites are not well-documented in the available literature. Â
Elimination and ExcretionÂ
The drug and its metabolites are eliminated from the body primarily through urine. The elimination half-life of oxaceprol can vary among individuals but is typically within a few hours.Â
Administration:Â
oxaceprol is typically administered orally in the form of tablets or capsules.Â
Patient information leafletÂ
Generic Name: oxaceprolÂ
Pronounced as: oxa-ce-prolÂ
Why do we use oxaceprol?Â